The Effect of Supervised Exercise on Physical Fitness and Energy Expenditure in Post Bariatric Surgery Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2008 by University of Texas Southwestern Medical Center.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
University of Texas Southwestern Medical Center
Information provided by:
University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT00793832
First received: November 17, 2008
Last updated: November 18, 2008
Last verified: November 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It is hypothesized that the patients in the EXDA group will be able to complete a structured exercise program at a level sufficient to accumulate at least 2000 kcal per week, and that the structured endurance activity will increase their physical fitness and total daily energy expenditure compared to the DA group.
| Condition | Intervention |
|---|---|
|
Post-Bariatric Surgery |
Behavioral: supervised exercise Behavioral: Diet advice |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Effect of Supervised Cardiorespiratory Endurance Exercise Training on Physical Fitness and Energy Expenditure in Roun-en-Y Gastric Bypass and Gastric Banding Surgery Patients. |
Resource links provided by NLM:
Further study details as provided by University of Texas Southwestern Medical Center:
Primary Outcome Measures:
- Exercise at a level sufficient to accumulate at least 2000kcal per week [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- To compare body weight and composition, quality of life, fasting lipids and lipoproteins, and glycemic control between the two groups. [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 30 |
| Study Start Date: | July 2007 |
| Estimated Study Completion Date: | February 2010 |
| Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1
Supervised exercise.
|
Behavioral: supervised exercise
supervised exercise
|
|
Active Comparator: 2
Diet Advice
|
Behavioral: Diet advice
Diet Advice
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- RYGB or GB surgery patients who are at least 12 weeks post surgery
- BMI of 40 or more
- age 18-70years
- sedentary lifestyle (energy expenditure of <35 kcal/kg/day measured by 7-day physical activity recall and no regular moderate physical activity exceeding 20 min/day within the previous 3 months)
- willingness to alter physical activity in accordance with the intervention programs
- English or Spanish speaking.
Exclusion Criteria:
- body weight > 180 kg
- cardiovascular disease
- pulmonary disease
- uncontrolled hypertension (resting DBP >100 or SBP >180 mm of Hg)
- visual or hearing impairment
- functional limitations (difficulty walking one-quarter mile or climbing 10 stairs)
- abnormal ECG on VO2max test ( >1 mm ST segment depression at < 5 METS or with symptoms such as atrial fibrillation, complex ventricular arrhythmias and 3rd degree atrioventricular block)
- known liver disease due to causes other than nonalcoholic steatohepatitis (liver transaminases > 2.5 times the upper limits of normal [SGPT>105 U/L, SGPT>120 U/L] or total bilirubin >1.5 mg/dL)
- hematocrit of less than 30%
- current alcohol abuse (>7 drinks or 210 g/wk for women and >14 drinks or 420 g/wk for men)
- recreational drug abuse
- current use of any drugs capable of inducing weight loss (e.g., orlistat, sibutramine, topiramate, etc.)
- major neuro-psychiatric illnesses impeding competence or compliance
- pregnancy and lactation
- chronic renal insufficiency (serum creatinine > 2 mg/dL)
- untreated thyroid disorders such as hypothyroidism and hyperthyroidism; and 17) bariatric surgical complications including anastomotic leak, wound complications, thrombotic disorders, intestinal obstruction, stomal complications, GI bleeding, recurrent severe abdominal pain, bilious vomiting.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00793832
Contacts
| Contact: Sneha Rao, M.B;B.S | 214-648-0548 | sneha.rao@utsouthwestern.edu |
| Contact: Meena Shah, Ph.D | 214-648-0543 | meena.shah@utsouthwestern.edu |
Locations
| United States, Texas | |
| UT Southwestern Medical Center | Recruiting |
| Dallas, Texas, United States, 75390 | |
| Principal Investigator: Meena Shah, Ph.D | |
Sponsors and Collaborators
University of Texas Southwestern Medical Center
Investigators
| Principal Investigator: | Meena Shah, Ph.D | UT Southwestern Medical Center |
More Information
No publications provided
| Responsible Party: | Abhimanyu Garg, M.D., UT Southwestern Medical Center |
| ClinicalTrials.gov Identifier: | NCT00793832 History of Changes |
| Other Study ID Numbers: | GCRC 837 |
| Study First Received: | November 17, 2008 |
| Last Updated: | November 18, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Texas Southwestern Medical Center:
|
weight loss |
ClinicalTrials.gov processed this record on June 17, 2013